Viz.ai announces collaboration with sanofi and regeneron to improve management and care of chronic obstructive pulmonary disease (copd)

San francisco--(business wire)-- #ai--viz.ai, the leader in ai-powered disease detection and intelligent care coordination, today announced a multi-year partnership with sanofi (nasdaq: sny), an innovative global healthcare company, and regeneron (nasdaq: regn), a leading biotechnology company, to deploy and evaluate an ai-powered workflow solution for chronic obstructive pulmonary disease (copd). with support from sanofi and regeneron, viz.ai will investigate the use of the viz copd module, a care a.
REGN Ratings Summary
REGN Quant Ranking